Concepedia

Q. Liu

QL

Statistics

Publications

3

Citations

184

H-Index

3

Active since

2000

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Q. Liu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, dipeptidyl peptidases, and drug disposition.

Publications per year

2000–2020

3

Publications

3

LBA8_PR Pembrolizumab plus chemotherapy versus chemotherapy as first-line therapy in patients with advanced esophageal cancer: The phase 3 KEYNOTE-590 study

Ken Kato, J-M. Sun, Manan Shah et al. · Annals of Oncology · 2020 · 131 citations

, , +9

Chromosomal localization<footref rid="foot01"><sup>1</sup></footref> of GPR48, a novel glycoprotein hormone receptor like GPCR, in human and mouse with radiation hybrid and interspecific backcross mapping

Evangeline D. Loh, Suzanne R. Broussard, Q. Liu et al. · Cytogenetic and Genome Research · 2000 · 31 citations

, , +11

Dose‐proportionality of a final market image sitagliptin formulation, an oral dipeptidyl peptidase‐4 inhibitor, in healthy volunteers

Arthur Bergman, Goutam C. Mistry, Wen‐Lin Luo et al. · Biopharmaceutics & Drug Disposition · 2007 · 22 citations

, , +13

1–3 of 3